Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-23

Clinical Trial Update: To Compare the Efficacy of Combined Tenofovir Plus Telbivudine vs Tenofovir Alone in Patients With Spontaneous Reactivation of Hepatitis B [NA]

View source ↗

Summary

A completed trial compared the efficacy of combining Tenofovir with Telbivudine versus Tenofovir alone in patients with spontaneous reactivation of Hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TENOFOVIR DISOPROXIL FUMARATE (tenofovir disoproxil fumarate)
  • Telbivudine (telbivudine)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Spontaneous Reactivation of Hepatitis B | NA | Status: COMPLETED